NEKTAR THERAPEUTICS — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B1
424B3
424B4
424B5
424B7
425
5
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
NTN 10K
POS AM
PRE 14A
REGDEX
RW
S-3
S-3/A
S-3ASR
S-8
S-8 POS
SC 13D
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001959173-25-005815 | Sep 5, 2025 | — |
| 144 | — | 0001959173-25-005776 | Sep 4, 2025 | — |
| 144 | — | 0001959173-25-005786 | Sep 4, 2025 | — |
| 4 | 4 | 0000950170-25-113129 | Sep 4, 2025 | Sep 2, 2025 |
| 4 | 4 | 0000950170-25-113130 | Sep 4, 2025 | Sep 2, 2025 |
| 144 | — | 0001959173-25-005717 | Sep 2, 2025 | — |
| 144 | — | 0001959173-25-005715 | Sep 2, 2025 | — |
| 4 | 4 | 0000950170-25-110773 | Aug 21, 2025 | Aug 19, 2025 |
| 4 | 4 | 0000950170-25-110775 | Aug 21, 2025 | Aug 19, 2025 |
| 4 | 4 | 0000950170-25-110774 | Aug 21, 2025 | Aug 19, 2025 |
| 144 | — | 0001959173-25-005340 | Aug 19, 2025 | — |
| 144 | — | 0001959173-25-005342 | Aug 19, 2025 | — |
| 144 | — | 0001959173-25-005343 | Aug 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-108881 | Aug 14, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-078723 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105275 | Aug 8, 2025 | Jun 30, 2025 |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-073234 | Aug 8, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-073100 | Aug 7, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-003310 | Jul 18, 2025 | — |
| SCHEDULE 13G | — | 0000921895-25-001976 | Jul 9, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-065729 | Jul 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-154062 | Jul 1, 2025 | Jun 30, 2025 |
| 424B5 | 424B5 | 0001193125-25-154036 | Jul 1, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-152827 | Jun 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-059115 | Jun 27, 2025 | Jun 24, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-056909 | Jun 24, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-052141 | Jun 6, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-051191 | Jun 4, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-047890 | May 28, 2025 | May 23, 2025 |
| 4 | 4 | 0000950170-25-075977 | May 21, 2025 | May 19, 2025 |
| 4 | 4 | 0000950170-25-075976 | May 21, 2025 | May 19, 2025 |
| 4 | 4 | 0000950170-25-075979 | May 21, 2025 | May 19, 2025 |
| 144 | — | 0001959173-25-003332 | May 19, 2025 | — |
| 144 | — | 0001959173-25-003331 | May 19, 2025 | — |
| 144 | — | 0001959173-25-003330 | May 19, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-003241 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-067279 | May 9, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-041085 | May 8, 2025 | — |
| ARS | ARS | 0001140361-25-015765 | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001140361-25-015744 | Apr 25, 2025 | May 23, 2025 |
| SCHEDULE 13G/A | — | 0001576419-25-000787 | Apr 17, 2025 | — |
| PRE 14A | PRE 14A | 0001140361-25-013973 | Apr 15, 2025 | May 23, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-029002 | Apr 4, 2025 | Apr 3, 2025 |
| EFFECT | — | 9999999995-25-000931 | Apr 1, 2025 | — |
| 8-K | CURRENT REPORT | 0001013762-25-004236 | Mar 28, 2025 | — |
| CORRESP | — | 0001193125-25-067201 | Mar 28, 2025 | — |
| S-3 | S-3 | 0001193125-25-067122 | Mar 28, 2025 | — |
| UPLOAD | — | 0000000000-25-003058 | Mar 20, 2025 | — |
| DRSLTR | — | 0000950123-25-003081 | Mar 14, 2025 | — |
| DRS | — | 0000950123-25-003079 | Mar 14, 2025 | — |